Health Care & Life Sciences » Biotechnology | Cerenis Therapeutics Holding

Cerenis Therapeutics Holding

Cerenis Therapeutics Holding S.A.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
18.31 M
Public Float
-
Cerenis Therapeutics Holding S.A.
Stock Exchange Euronext Paris
EPS
EUR0.34
Market Cap
EUR6.81 M
Shares Outstanding
21.95 M
Public Float
11.36 M

Profile

Address
33-43, av. Georges Pompidou- Bât. D2
Balma Midi-Pyrenees 31130
France
Employees -
Website http://www.cerenis.com
Updated 07/08/2019
Cerenis Therapeutics Holding SA is a biopharmaceutical company, which engages in development of high density lipoprotein therapies for the treatment of cardiovascular and metabolic diseases. Its therapies consist of CER 001 and 209. The company was founded by Jean-Louis Dasseux on March 24, 2005 and is headquartered in Labege, France.

Financials

View All
Created with Highcharts 5.0.14Cerenis Therapeutics Holding S.A.Net Income. Fiscal year is January-December. All values EUR Thousands.7 7427 7426 5636 56316 63816 63824 87124 8714 9784 9786 3056 30520132014201520162017201805k10k15k20k25k30k

Richard C. Pasternak
Chairman
Jean-Louis Dasseux
President, Chief Executive Officer & Director